Drug Profile
Carcinoderm
Alternative Names: CarcinodermLatest Information Update: 22 Feb 2007
Price :
$50
*
At a glance
- Originator Bio-Life Labs
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Skin cancer
Most Recent Events
- 06 Sep 2004 Clinical trials in Skin cancer in USA (Topical)